安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2009年
7期
794-796
,共3页
脑出血%微创%血肿清除术
腦齣血%微創%血腫清除術
뇌출혈%미창%혈종청제술
Intracerebral hemorrhage%Microinvasive%Evacuation of hematoma
目的 探讨颅内血肿微创清除术对高血压性脑出血的临床疗效、手术时机选择和基层医院开展的可行性.方法 开展的微创治疗脑出血24例为微创组,内科治疗的脑出血26例为对照组,分析两组疗效.结果 有效率微创组87.5%,对照组为50%(P<0.01).两组病死率分别为4.2%和19.2%(P<0.01).存活患者的生存质量对比,微创组也明显优于对照组.本组发病后选择手术时间平均为24.2小时.结论 颅内血肿微创清除术治疗脑出血其疗效明显,手术时机选择1~3天为宜,适合基层医院开展.
目的 探討顱內血腫微創清除術對高血壓性腦齣血的臨床療效、手術時機選擇和基層醫院開展的可行性.方法 開展的微創治療腦齣血24例為微創組,內科治療的腦齣血26例為對照組,分析兩組療效.結果 有效率微創組87.5%,對照組為50%(P<0.01).兩組病死率分彆為4.2%和19.2%(P<0.01).存活患者的生存質量對比,微創組也明顯優于對照組.本組髮病後選擇手術時間平均為24.2小時.結論 顱內血腫微創清除術治療腦齣血其療效明顯,手術時機選擇1~3天為宜,適閤基層醫院開展.
목적 탐토로내혈종미창청제술대고혈압성뇌출혈적림상료효、수술시궤선택화기층의원개전적가행성.방법 개전적미창치료뇌출혈24례위미창조,내과치료적뇌출혈26례위대조조,분석량조료효.결과 유효솔미창조87.5%,대조조위50%(P<0.01).량조병사솔분별위4.2%화19.2%(P<0.01).존활환자적생존질량대비,미창조야명현우우대조조.본조발병후선택수술시간평균위24.2소시.결론 로내혈종미창청제술치료뇌출혈기료효명현,수술시궤선택1~3천위의,괄합기층의원개전.
Objective To discuss the clinical effect of microinvasive evacuation of hematoma in treatment of hypertensive intracere-bral hemorrhage, also the best time of the operation and the feasibility of being carried out in substrate hospital were studied. Methods 24 patients were treated with microinvasive evacuation. The therapy effect was compared with the effects of conservative internal medicine for control group (26 patients). Results The effective rate and fatality rate of this therapy which were 87.5% and 4. 2% respectively, were significantly different from the control group(P<0.01), which were 50% and 19.2% respectively. After operation, the patients'quality of life was obviously improved compared with that in control group. We found the best opportunity of the operation was about 24.2 hours after brain hemorrhage. Conclusion The therapeutic effect of microinvasive evacuation of hematoma in treatment of hypertensive intracercbral hemorrhage was significantly better than that of conservative internal medicine. As this therapy was easy to practice and then could be carried out in substrate hospital. The operation could be put into practice in 1 -3 days after intracerebral hemorrhage.